SE8304857D0 - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number
SE8304857D0
SE8304857D0 SE8304857A SE8304857A SE8304857D0 SE 8304857 D0 SE8304857 D0 SE 8304857D0 SE 8304857 A SE8304857 A SE 8304857A SE 8304857 A SE8304857 A SE 8304857A SE 8304857 D0 SE8304857 D0 SE 8304857D0
Authority
SE
Sweden
Prior art keywords
compositions
pharmaceutical compositions
preferred
base
ceftazidime
Prior art date
Application number
SE8304857A
Other languages
English (en)
Other versions
SE464615B (sv
SE8304857L (sv
Inventor
B L Richardson
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of SE8304857D0 publication Critical patent/SE8304857D0/sv
Publication of SE8304857L publication Critical patent/SE8304857L/sv
Publication of SE464615B publication Critical patent/SE464615B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
SE8304857A 1982-09-10 1983-09-09 Fast farmaceutisk komposition med foerbaettrad stabilitet innehaallande ett eller flera beta-laktamantibiotika SE464615B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8225853 1982-09-10

Publications (3)

Publication Number Publication Date
SE8304857D0 true SE8304857D0 (sv) 1983-09-09
SE8304857L SE8304857L (sv) 1984-03-11
SE464615B SE464615B (sv) 1991-05-27

Family

ID=10532830

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8304857A SE464615B (sv) 1982-09-10 1983-09-09 Fast farmaceutisk komposition med foerbaettrad stabilitet innehaallande ett eller flera beta-laktamantibiotika

Country Status (20)

Country Link
US (2) US4582830A (sv)
JP (1) JPS5973518A (sv)
KR (1) KR880001094B1 (sv)
AT (1) AT388671B (sv)
AU (1) AU566245B2 (sv)
BE (1) BE897721A (sv)
CA (1) CA1215647A (sv)
CH (1) CH655008A5 (sv)
DE (1) DE3332616C2 (sv)
DK (1) DK161304C (sv)
ES (1) ES8502863A1 (sv)
FR (1) FR2532849B1 (sv)
GB (1) GB2126479B (sv)
IE (1) IE55720B1 (sv)
IT (1) IT1197708B (sv)
NL (1) NL189948C (sv)
NZ (1) NZ205539A (sv)
PT (1) PT77323B (sv)
SE (1) SE464615B (sv)
ZA (1) ZA836703B (sv)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4626534A (en) * 1984-07-23 1986-12-02 Eli Lilly And Company Pharmaceutical formulation
AT393452B (de) * 1985-08-05 1991-10-25 Bristol Myers Squibb Co Verfahren zur herstellung eines cephalosporinpraeparates zur herstellung einer injektionsloesung
WO1988009173A1 (en) * 1987-05-27 1988-12-01 Akzo N.V. DRY, RAPIDLY SOLUBLE, COMPOSITIONS OF beta-LACTAM ANTIBIOTICS
IE61679B1 (en) * 1987-08-10 1994-11-16 Fujisawa Pharmaceutical Co Water-soluble antibiotic composition and water-soluble salts of new cephem compounds
EP0797974B1 (en) * 1994-12-08 2000-08-30 Otsuka Pharmaceutical Factory, Inc. Method of suppressing adsorption of substances derived from container material on drugs
HRP970281B1 (en) * 1996-05-28 2002-04-30 Merck & Co Inc Carbapenem antibiotic, composition and method of preparation
CA2239331C (en) * 1998-05-29 1999-11-30 Bernard Charles Sherman Pharmaceutical tablets comprising cefuroxime axetil
JP4700291B2 (ja) * 2003-04-28 2011-06-15 武田薬品工業株式会社 注射用組成物
EP1618894B1 (en) * 2003-04-28 2018-06-13 Takeda Pharmaceutical Company Limited Composition for injection
EP1625859A1 (en) * 2004-08-13 2006-02-15 Access Group ApS A process for the preparation of a package comprising a sterilised bulk of a substance, and a package comprising a sterilised bulk of a penicilin
CN102920710B (zh) * 2012-11-16 2014-05-28 罗诚 一种头孢地嗪化合物的药物组合物
CN103432137B (zh) * 2013-08-28 2015-01-28 芦红代 头孢西丁的药物组合物
CN113350511B (zh) * 2021-03-01 2024-01-02 郎俊娜 一种新型注射用无菌粉末灌装混合保护气

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB737242A (en) * 1952-10-16 1955-09-21 Novo Terapeutisk Labor As Process of increasing the physical stability of aqueous suspensions of penicillin compounds
GB760087A (en) * 1952-10-16 1956-10-31 Novo Terapeutisk Labor As Process of increasing the physical stability of aqueous suspensions of penicillin compounds
GB1132583A (en) * 1964-12-16 1968-11-06 Glaxo Lab Ltd Pharmaceutical compositions containing cephalosporins
GB1276839A (en) * 1968-08-02 1972-06-07 Sandoz Products Ltd Antibiotic compositions
AT307616B (de) * 1969-05-02 1973-05-25 Biochemie Gmbh Verfahren zur Herstellung einer Brausezubereitung
US3940483A (en) * 1971-02-05 1976-02-24 E. R. Squibb & Sons, Inc. Antibiotic compositions and method
GB1380741A (en) * 1971-02-05 1975-01-15 Squibb & Sons Inc Antibiotic compositions and their preparation
LU65921A1 (sv) * 1972-08-18 1974-02-21
US4160829A (en) * 1972-12-22 1979-07-10 Gist-Brocades N.V. Antibacterial 1,2,4-oxadiazolylacetamido cephalosporins
US3969524A (en) * 1974-08-13 1976-07-13 Hoffmann-La Roche Inc. Stable amoxicillin dosage form
GB1463563A (en) * 1974-10-10 1977-02-02 Beecham Group Ltd Pharmaceutical compositions
DE2461969A1 (de) * 1974-12-31 1976-07-08 Behringwerke Ag Stabiles blutplasma, verfahren zu dessen herstellung und seine verwendung als vergleichsplasma bei gerinnungs- untersuchungen
CA1051780A (en) * 1975-04-09 1979-04-03 Bahram Farhadieh Stable chelocardin composition
GB1575905A (en) * 1976-04-28 1980-10-01 Glaxo Lab Ltd Salt of cefuroxime
GB1504767A (en) * 1976-08-23 1978-03-22 Beecham Group Ltd Antibiotic compositions
JPS5329936A (en) * 1976-08-31 1978-03-20 Takeda Chem Ind Ltd Antibiotic composition
FR2403078A1 (fr) * 1977-09-19 1979-04-13 Lafon Labor Nouveau procede de preparation de formes pharmaceutiques, cosmetiques ou de diagnostic
ZA785711B (en) * 1977-10-10 1979-09-26 Glaxo Group Ltd B-lactam compounds,process for their preparation,pharmaceutical compositions containing them and intermediates of use in their preparation
AR229883A1 (es) * 1978-05-26 1983-12-30 Glaxo Group Ltd Procedimiento para la preparacion de antibiotico(6r,7r)-7-((z)-2-(2-aminotiazol-4-il)-2-(2-carboxiprop-2-oxiimino)-acetamido)-3-(1-piridinometil)-cef-3-em-4-carboxilato
PT70225A (en) * 1978-10-03 1979-10-01 Gist Brocades Nv Process for the preparation of sodium amoxicillin preparations
US4235900A (en) * 1978-11-15 1980-11-25 E. R. Squibb & Sons, Inc. Cephradine compositions
FR2445833A1 (fr) * 1979-01-04 1980-08-01 Chimie Biolog Nouveaux sels d'antibiotiques amines a cycle beta lactame
US4329453A (en) * 1979-10-02 1982-05-11 Glaxo Group Limited Cephalosporin antibiotic

Also Published As

Publication number Publication date
IE55720B1 (en) 1991-01-02
ZA836703B (en) 1984-10-31
US4582830A (en) 1986-04-15
IE832118L (en) 1984-03-10
CH655008A5 (de) 1986-03-27
DK161304C (da) 1991-12-02
NL189948B (nl) 1993-04-16
ATA322783A (de) 1989-01-15
AU566245B2 (en) 1987-10-15
DK409183D0 (da) 1983-09-09
GB2126479A (en) 1984-03-28
IT1197708B (it) 1988-12-06
US4803196A (en) 1989-02-07
SE464615B (sv) 1991-05-27
ES525492A0 (es) 1985-02-01
JPH0480883B2 (sv) 1992-12-21
PT77323A (en) 1983-10-01
DE3332616A1 (de) 1984-03-15
NZ205539A (en) 1986-03-14
FR2532849A1 (fr) 1984-03-16
NL8303125A (nl) 1984-04-02
CA1215647A (en) 1986-12-23
JPS5973518A (ja) 1984-04-25
KR840006126A (ko) 1984-11-22
GB2126479B (en) 1986-04-03
ES8502863A1 (es) 1985-02-01
FR2532849B1 (fr) 1986-08-22
DK409183A (da) 1984-03-11
PT77323B (en) 1986-02-06
GB8324133D0 (en) 1983-10-12
KR880001094B1 (ko) 1988-06-29
DK161304B (da) 1991-06-24
AU1897583A (en) 1984-03-15
NL189948C (nl) 1993-09-16
BE897721A (fr) 1984-03-09
SE8304857L (sv) 1984-03-11
AT388671B (de) 1989-08-10
IT8348950A0 (it) 1983-09-09
DE3332616C2 (de) 1995-06-01

Similar Documents

Publication Publication Date Title
SE8304857L (sv) Farmaceutiska kompositioner
ES2098842T3 (es) Composicion farmaceutica estabilizada y disolvente estabilizante.
HU9203623D0 (en) High-dosed forms of collagenase for local applications
DE3675083D1 (de) Material zum ausfuellen von periodontalen knochendefekten.
HUT72325A (en) Stabile, liophylised composition containing proteins and kit applicabe for dosing
NO923948D0 (no) Tiofensulfonamider som kan anvendes som karbonsyre-anhydraseinhibitorer
ES2082011T3 (es) Procedimiento y composicion para extinguir fuegos.
YU4198A (sh) Karbapenem antibiotik, kompozicija i postupak za dobijanje
SE415298B (sv) Forfarande for bestemning av ammoniak i en gasblandning som innerhaller andelar av kveveoxid och kvevedioxid
ATE6907T1 (de) Zahncreme mit hohem schaumvermoegen.
ATE265490T1 (de) Zusammensetzung enthaltend feine feststoffteilchen
SE7703206L (sv) Stabiliserad ureas
FI791565A (fi) Farmaceutiska sammansaettningar innehaollande prostaglandinfoereningar
JO1337B1 (en) Pharmaceutical compounds
DE3771260D1 (de) Kalziumkarbonatsuspension enthaltende pharmazeutische zusammensetzung.
GB1035005A (en) Local anesthetic preparations and process of making same
SE8200757L (sv) Biologiskt aktiva peptider
Yocom Materials as sinks and sources of indoor air pollution.
ES2033501T3 (es) Procedimiento para la preparacion de polisulfuros de sodio inferiores a partir de polisulfuros de sodio superiores y sodio.
ATE33552T1 (de) Dermatologische praeparate.
ES2059387T3 (es) Concentrado de estabilizante mejorado.
ATE461711T1 (de) Zusammensetzung zur stabilisierung von fettlöslichen vitaminen in wässeriger lösung
SU1125965A1 (ru) Трехкомпонентная фторидная солевая смесь
AU494778B2 (en) Determining the concentration of gaseous components ina mixture of gases
IT1241459B (it) Composizioni farmaceutiche per la somministrazione rettale di calcitonina

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8304857-9

Format of ref document f/p: F

NUG Patent has lapsed